News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
752,165 Results
Type
Article (44467)
Company Profile (468)
Press Release (707214)
Multimedia
Podcasts (150)
Webinars (23)
Section
Business (209972)
Career Advice (2187)
Deals (36278)
Drug Delivery (142)
Drug Development (84233)
Employer Resources (174)
FDA (16857)
Job Trends (15267)
News (355468)
Policy (33377)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2701)
Accelerated approval (58)
ADA (49)
Adcomms (33)
Allergies (196)
Alliances (51156)
ALS (232)
Alzheimer's disease (1896)
Antibody-drug conjugate (ADC) (533)
Approvals (17269)
Artificial intelligence (754)
ASCO (337)
Autoimmune disease (344)
Automation (60)
Bankruptcy (374)
Best Places to Work (11858)
BIOSECURE Act (20)
Biosimilars (234)
Biotechnology (325)
Bladder cancer (206)
Brain cancer (78)
Breast cancer (808)
Cancer (6390)
Cardiovascular disease (520)
Career advice (1872)
Career pathing (46)
CAR-T (365)
CDC (59)
Celiac Disease (3)
Cell therapy (994)
Cervical cancer (54)
Clinical research (73354)
Collaboration (2293)
Commercialization (1)
Company closure (5)
Compensation (1510)
Complete response letters (94)
COVID-19 (2817)
CRISPR (123)
C-suite (1262)
Cystic fibrosis (165)
Data (8679)
Decentralized trials (3)
Denatured (47)
Depression (184)
Dermatology (96)
Diabetes (671)
Diagnostics (7093)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (373)
Drug pricing (213)
Drug shortages (32)
Duchenne muscular dystrophy (316)
Earnings (93801)
Editorial (71)
Employer branding (21)
Employer resources (153)
Events (124742)
Executive appointments (1153)
FDA (20841)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1902)
Gene editing (263)
Generative AI (62)
Gene therapy (807)
GLP-1 (1141)
Government (4857)
Grass and pollen (6)
Guidances (416)
Healthcare (19524)
Hematology (194)
HIV (91)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (329)
Immuno-oncology (111)
Indications (213)
Infectious disease (3190)
Inflammatory bowel disease (231)
Inflation Reduction Act (17)
Influenza (144)
Intellectual property (319)
Interviews (359)
IPO (16984)
IRA (53)
Job creations (3729)
Job search strategy (1524)
JPM (67)
Kidney cancer (20)
Labor market (110)
Layoffs (608)
Leadership (43)
Legal (8059)
Liver cancer (105)
Longevity (35)
Lung cancer (846)
Lymphoma (476)
Machine learning (64)
Management (59)
Manufacturing (1152)
Marketing (1)
MASH (215)
Medical affairs (1)
Medical device (14164)
Medtech (14325)
Mergers & acquisitions (20593)
Metabolic disorders (1703)
mRNA (255)
Multiple sclerosis (201)
NASH (20)
Neurodegenerative disease (480)
Neuropsychiatric disorders (119)
Neuroscience (3586)
Neurotech (1)
NextGen: Class of 2026 (6797)
Non-profit (4639)
Now hiring (81)
Obesity (795)
Opinion (317)
Ovarian cancer (240)
Pain (272)
Pancreatic cancer (352)
Parkinson's disease (409)
Partnered (36)
Patents (634)
Patient recruitment (756)
Peanut (67)
People (61356)
Pharmaceutical (80)
Pharmacy benefit managers (34)
Phase 1 (23079)
Phase 2 (32381)
Phase 3 (23889)
Pipeline (9750)
Policy (344)
Postmarket research (2607)
Preclinical (9893)
Press Release (67)
Prostate cancer (343)
Psychedelics (67)
Radiopharmaceuticals (365)
Rare diseases (1222)
Real estate (6088)
Recruiting (71)
Regulatory (26290)
Reports (56)
Research institute (2525)
Resumes & cover letters (379)
Rett syndrome (42)
RNA editing (29)
RSV (90)
Schizophrenia (190)
Series A (326)
Series B (240)
Service/supplier (11)
Sickle cell disease (127)
Special edition (29)
Spinal muscular atrophy (172)
Sponsored (49)
Startups (3844)
State (2)
Stomach cancer (19)
Supply chain (138)
Tariffs (88)
The Weekly (100)
Vaccines (1172)
Venture capital (127)
Weight loss (517)
Women's health (139)
Worklife (21)
Date
Today (95)
Last 7 days (514)
Last 30 days (2734)
Last 365 days (31258)
2026 (15919)
2025 (31077)
2024 (36323)
2023 (41053)
2022 (52323)
2021 (56818)
2020 (55014)
2019 (47548)
2018 (35831)
2017 (33111)
2016 (32446)
2015 (38470)
2014 (32255)
2013 (27165)
2012 (29283)
2011 (29936)
2010 (28053)
Location
Africa (763)
Alabama (99)
Alaska (7)
Arizona (376)
Arkansas (16)
Asia (41468)
Australia (6904)
California (14141)
Canada (3943)
China (1522)
Colorado (606)
Connecticut (629)
Delaware (434)
Europe (91488)
Florida (2103)
Georgia (449)
Hawaii (3)
Idaho (63)
Illinois (1159)
India (97)
Indiana (632)
Iowa (26)
Japan (597)
Kansas (137)
Kentucky (53)
Louisiana (59)
Maine (76)
Maryland (1678)
Massachusetts (10264)
Michigan (384)
Minnesota (765)
Mississippi (6)
Missouri (157)
Montana (35)
Nebraska (30)
Nevada (148)
New Hampshire (89)
New Jersey (3715)
New Mexico (33)
New York (3683)
North Carolina (1840)
North Dakota (10)
Northern California (7113)
Ohio (422)
Oklahoma (23)
Oregon (44)
Pennsylvania (2792)
Puerto Rico (31)
Rhode Island (53)
South America (1134)
South Carolina (86)
South Dakota (2)
Southern California (5577)
Tennessee (225)
Texas (2258)
United States (50043)
Utah (418)
Vermont (2)
Virginia (348)
Washington D.C. (82)
Washington State (1153)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
752,165 Results for "click therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Click Therapeutics and Boehringer Ingelheim Announce Series D Investment and Funding to Advance Commercialization of CT-155
April 9, 2026
·
8 min read
Press Releases
SEQSTER Launches 1-Click Sites™ to Transform Clinical Sites into Research-Ready Data Collection Points: Names BioIVT as First Deployment Partner
April 17, 2026
·
4 min read
Pharm Country
Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of Better Therapeutics, Inc.
May 22, 2024
·
7 min read
Press Releases
Boehringer and Click Therapeutics present pivotal data for investigational prescription digital therapeutic CT-155 showing a statistically significant reduction in negative symptoms of schizophrenia
October 14, 2025
·
13 min read
Press Releases
Crescita Therapeutics Inc. Announces Closing of Arrangement
June 4, 2026
·
3 min read
Press Releases
Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting
June 19, 2026
·
5 min read
Press Releases
BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors
June 8, 2026
·
5 min read
Business
Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of Rejoyn
Otsuka Pharmaceutical, Co. Ltd. (Otsuka) and Click Therapeutics, Inc., (Click) announce that the U.S. Food and Drug Administration (FDA) has cleared Rejoyn.
April 1, 2024
·
12 min read
Press Releases
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.
June 10, 2026
·
11 min read
Press Releases
Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia
August 8, 2025
·
9 min read
1 of 75,217
Next
